Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors

Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors

Objective:. To determine the association of primary tumor resection in stage IV pancreatic neuroendocrine tumors (Pan-NET) and survival in a propensity-score matched study. Background:. Pan-NET are often diagnosed with stage IV disease. The oncologic benefit from primary tumor resection in this scen...

Full description

Bibliographic Details
Main Authors: Josefine Kjaer, MD, Thomas E. Clancy, MD, Anders Thornell, MD, PhD, Niklas Andersson, MD, Per Hellman, MD, PhD, Joakim Crona, MD, PhD, Staffan Welin, MD, PhD, Megan Sulciner, MD, Brittany Powell, MD, Lauren Brais, MPH, Kristina Astone, MPH, William Baddoo, BA, Gerhard Doherty, MD, Jennifer A. Chan, MD, MPH, Olov Norlén, MD, PhD, Peter Stålberg, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer Health 2022-03-01
Series:Annals of Surgery Open
Online Access:http://journals.lww.com/10.1097/AS9.0000000000000151

Internet

http://journals.lww.com/10.1097/AS9.0000000000000151

Similar Items